Actively Recruiting

Phase Not Applicable
Age: 18Years +
MALE
NCT07180381

Sequential Imaging of Suspicion of Prostate Cancer Reducing Overdiagnosis and Unnecessary Biopsy With Timely Diagnosis of Significant Cancer

Led by St. Antonius Hospital · Updated on 2025-12-04

503

Participants Needed

7

Research Sites

294 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to evaluate the safety and effectiveness of a novel diagnostic strategy for prostate cancer, in which men with a moderate risk of prostate cancer are monitored using PSA and MRI instead of immediate biopsy,. The main questions it aims to answer are: * Is it safe to delay biopsy, making sure that clinical significant prostate cancers are not often missed? * Does it reduce unnecessary biopsies and overtreatment?

CONDITIONS

Official Title

Sequential Imaging of Suspicion of Prostate Cancer Reducing Overdiagnosis and Unnecessary Biopsy With Timely Diagnosis of Significant Cancer

Who Can Participate

Age: 18Years +
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Life expectancy greater than 10 years
  • Initial PSA less than 20 ng/ml
  • No signs of extracapsular disease on digital rectal examination
  • Intermediate-risk prostate cancer suspicion based on MRI: PI-RADS 3 or 4 with PSA density 0.15 or less
  • Mentally competent and able to understand study benefits and risks
  • Willing to follow the monitoring protocol for up to four years
  • Provided written and signed informed consent
Not Eligible

You will not qualify if you...

  • Previously had a prostate biopsy
  • Prior diagnosis of prostate cancer
  • Currently using any hormonal or anti-hormonal therapies, including 5-alpha-reductase inhibitors
  • Known germline mutation for prostate cancer (e.g., BRCA1, BRCA2)
  • Active treatment for another cancer besides basal cell carcinoma of the skin
  • Severe claustrophobia or other conditions making MRI scans unsafe (e.g., metal implants, pacemakers)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 7 locations

1

Treant

Emmen, Drenthe, Netherlands, 7824AA

Actively Recruiting

2

Andros Clinics

Arnhem, Gelderland, Netherlands, 6842 CV

Actively Recruiting

3

Radboud University Medical Centre

Nijmegen, Gelderland, Netherlands, 6525 GA

Actively Recruiting

4

Canisius Wilhelmina Hospital

Nijmegen, Gelderland, Netherlands

Actively Recruiting

5

Antoni van Leeuwenhoek Hospital

Amsterdam, North Holland, Netherlands

Actively Recruiting

6

Maasstad Hospital

Rotterdam, South Holland, Netherlands

Not Yet Recruiting

7

St Antonius Hospital

Nieuwegein, Utrecht, Netherlands, 3435 CM

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here